Myomo Inc.

11/10/2025 | Press release | Distributed by Public on 11/10/2025 15:11

Myomo Reports Third Quarter 2025 Financial and Operating Results

Revenue of $10.1 million

229 authorizations and orders, highest number this year

Reiterates full year revenue guidance of $40 million to $42 million

Conference call begins today at 4:30pm Eastern time

BURLINGTON, Mass. (November 10, 2025) - Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three and nine months ended September 30, 2025. Read more.

Myomo Inc. published this content on November 10, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 10, 2025 at 21:11 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]